ACE-031, a research investigational drug, was explored for its potential to promote muscle growth and increase strength. Studies examined its effects on specific muscle groups and overall body composition in various populations, including athletes and individuals with muscle-wasting conditions. For example, researchers investigated changes in lean body mass and functional performance metrics following administration.
The potential for enhanced muscle development and improved physical function generated significant interest in the compound’s application within the bodybuilding community. This interest stemmed from the desire to accelerate muscle gains and potentially mitigate age-related muscle loss. While showing initial promise, further development of the drug was discontinued, underscoring the importance of evidence-based practices and thorough research in pursuing fitness goals.